DAXOR CORP
DXRNasdaq
$10.90
↑ +3.7%Jul 17 close · end-of-day
Price
1Y↑ +17.1%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
No screener snapshot for this ticker.
Company profile
Daxor Corporation provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition.
- CEO
- Michael R. Feldschuh
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 37
- Headquarters
- New York
- Website
- daxor.com
Management & directors
- Feldschuh Jonathan AdamChief Scientific Officer
- Feldschuh Michael RichardChief Executive Officer
- Michel Robert JChief Financial Officer
- Jefferies JohnChief Medical Officer
Roles derived from SEC Form 4 filings.
Earnings
No reported earnings periods on file.
Financial statements
No annual data.
No quarterly data.
Company news
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-23 | Michel Robert J· Chief Financial Officer | Award | 12,000 | $0.00 | $0.00 | filing |
| 2026-06-23 | Feldschuh Michael Richard· Chief Executive Officer | Award | 30,000 | $0.00 | $0.00 | filing |
| 2026-06-23 | Feldschuh Jonathan Adam· Chief Scientific Officer | Award | 25,000 | $0.00 | $0.00 | filing |
| 2026-04-08 | Feldschuh Michael Richard· Chief Executive Officer | Buy | 1,000 | $9.07 | $9,070.00 | filing |
| 2026-03-31 | Michel Robert J· Chief Financial Officer | Buy | 1,000 | $9.90 | $9,900.00 | filing |
| 2026-03-20 | Jefferies John· Chief Medical Officer | Buy | 3,656 | $0.00 | $0.00 | filing |
| 2026-03-20 | Jefferies John· Chief Medical Officer | Buy | 2,285 | $0.00 | $0.00 | filing |
| 2025-12-09 | Michel Robert J· Chief Financial Officer | Buy | 3,000 | $0.00 | $0.00 | filing |
| 2025-12-09 | Feldschuh Jonathan Adam· Chief Scientific Officer | Buy | 18,000 | $0.00 | $0.00 | filing |
| 2025-11-12 | Jefferies John· Chief Medical Officer | Buy | 2,344 | $0.00 | $0.00 | filing |
Latest 10 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.